Please provide your email address to receive an email when new articles are posted on . An FDA panel voted that for adults with uncontrolled hypertension, the benefits of an ultrasound renal ...

Educated Patient® Kidney Cancer Summit Combination Therapy Panel: April 9, 2022 This panel featured Dr. Thomas Hutson, Dr. Saby George, Dr. Jeff Yorio, and Louise Gunter.

Please provide your email address to receive an email when new articles are posted on . An FDA panel voted that for adults with uncontrolled hypertension, the benefits of a radiofrequency renal ...

Adding cystatin C to serum creatinine testing better-identified patients at risk for end-stage kidney disease and all-cause death, new study findings indicate. “Our results suggest that a ...

Silver Spring, MD - A US Food and Drug Administration advisory panel is generally in agreement that at least two gadolinium contrast dyes, gadodiamide (Omniscan, GE Healthcare) and gadoversetamide ...

This panel was moderated by Kristie L. Kahl and featured Dr. Thomas Hutson, Louise Gunter and Meryl Uranga. Kahl: I want to shift gears to talk about side effects and dose reductions. So Louise, I ...

Standardizing follow-up after kidney stone treatment may reduce ionizing radiation exposure, identify recurrences earlier, and avoid complications such as urosepsis and chronic kidney disease, ...

NEW YORK and SALT LAKE CITY, Nov. 10, 2021 (GLOBE NEWSWIRE) -- In recognition of National Diabetes Month and concurrent with the launch of KidneyIntelX in the Veterans Health Administration health ...

An expert panel of US nephrologists and other health care providers unanimously agreed that secondary hyperparathyroidism treatment is often started too late in patients with chronic kidney disease. A ...

The US Food and Drug Administration's (FDA's) Circulatory System Devices Panel unanimously agreed that the Symplicity Spyral Renal Denervation System (Medtronic, Inc.) is safe, but the panel was split ...